NM_001184880.2:c.3299A>G
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_001184880.2(PCDH19):c.3299A>G(p.Asn1100Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000662 in 1,209,050 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. N1100N) has been classified as Likely benign.
Frequency
Consequence
NM_001184880.2 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 9Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- Dravet syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PCDH19 | NM_001184880.2 | c.3299A>G | p.Asn1100Ser | missense_variant | Exon 6 of 6 | ENST00000373034.8 | NP_001171809.1 | |
| PCDH19 | NM_001105243.2 | c.3158A>G | p.Asn1053Ser | missense_variant | Exon 5 of 5 | NP_001098713.1 | ||
| PCDH19 | NM_020766.3 | c.3155A>G | p.Asn1052Ser | missense_variant | Exon 5 of 5 | NP_065817.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PCDH19 | ENST00000373034.8 | c.3299A>G | p.Asn1100Ser | missense_variant | Exon 6 of 6 | 1 | NM_001184880.2 | ENSP00000362125.4 | ||
| PCDH19 | ENST00000255531.8 | c.3158A>G | p.Asn1053Ser | missense_variant | Exon 5 of 5 | 1 | ENSP00000255531.7 | |||
| PCDH19 | ENST00000420881.6 | c.3155A>G | p.Asn1052Ser | missense_variant | Exon 5 of 5 | 1 | ENSP00000400327.2 | |||
| PCDH19 | ENST00000464981.1 | n.-125A>G | upstream_gene_variant | 3 | ENSP00000479805.1 |
Frequencies
GnomAD3 genomes AF: 0.00000899 AC: 1AN: 111179Hom.: 0 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.0000330 AC: 6AN: 181571 AF XY: 0.0000592 show subpopulations
GnomAD4 exome AF: 0.00000638 AC: 7AN: 1097871Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 4AN XY: 363229 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000899 AC: 1AN: 111179Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33383 show subpopulations
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 9 Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 1100 of the PCDH19 protein (p.Asn1100Ser). This variant is present in population databases (rs777494666, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with PCDH19-related conditions. ClinVar contains an entry for this variant (Variation ID: 575044). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt PCDH19 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at